<i>NeuroD1</i>A45T and<i>PAX4</i>R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes

Zhicheng Gong, Qiong Huang, Xing‐Ping Dai, Guanghua Lei, Hong‐Bin Lu, Ji‐Ye Yin, Xiaojing Xu, Jian Qu, Qi Pei, Min Dong,

British Journal of Clinical Pharmacology · 2012 · 29 citations · 35 references

DOIFull text

Open access

Abstract

The NeuroD1/BETA2 and PAX4 polymorphisms were substantially associated with plasma glucose level after repaglinide monotherapy.

References

35